3 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Mutanome Engineered RNA Immuno-Therapy (MERIT)
Date du début: 1 juin 2013, Date de fin: 30 nov. 2017,
...inical-grade RNA to produce a) a warehouse of therapeutic vaccines targeting shared antigens and b) custom therapeutic vaccines targeting patient-specific mutations. Upon success, partner BioNTech will move the therapeutics to advanced clinical trials and commercial applications for the benefit of triple negative breast cancer patients and other solid tumours.
Voir le projet
5
Participants partenaires
TERMINÉ
Initial Training Network for Neurogical disorders orchestrated by cytoKines (NEUROKINE)
Date du début: 1 janv. 2013, Date de fin: 31 mai 2017,
Neuroinflammatory disease, in particular multiple sclerosis affects more than 700.000 people within Europe alone. European countries are at the forefront of neuroimmunological research and students in medicine and biology are greatly attracted by the field. Neuroimmunology research further impacts our understanding of the ethiopathology of other CNS-disorders including Alzheimer’s Dementia and Mor ...
Voir le projet
13
Participants partenaires
TERMINÉ
Glioma Actively Personalized Vaccine Consortium (GAPVAC)
Date du début: 1 nov. 2012, Date de fin: 31 janv. 2017,
"Glioblastoma (GBM) is a rare (2-3 incidences in 100,000) and fatal disease. Each year, approximately 13,000 new cases of GBM are diagnosed in Europe. The 5-year survival rate of this highly aggressive tumor entity under conventional therapy is less than 6%. Currently available therapeutic options neglect the individuality of each patients’ disease and only temporarily influence tumor progression ...
Voir le projet